Skip to contentSkip to Braille Studio

Library / Laws / 116th Congress / Senate Bills / S. 3021

S. 3021

To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2019-12-111.5K⠃⠗⠋